Literature DB >> 6183996

Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection.

K W Jericho, W D Yates, L A Babiuk.   

Abstract

The onset of protection offered by intranasal vaccination with attenuated bovine herpesvirus-1 (BHV-1) was studied in 18 calves given a virulent BHV-1 aerosol challenge inoculum and an aerosol challenge exposure to Pasteurella haemolytica. Calves challenge exposed with virus 3, 7, 11, 15, or 19 days after vaccination and challenge exposed 4 days later with Pasteurella haemolytica did not develop viral-bacterial pneumonia, whereas 2 of 3 control calves died of fibrinous bronchopneumonia 40 and 60 hours after the bacterial aerosol and the 3rd control calf had similar lesions. All vaccinated and control calves had detectable amounts of interferon at the time of viral challenge exposure. Protection was observed before detection of neutralizing antibodies to BHV-1 in nasal secretions or in serum. Protection was therefore present from day 3 through day 19 after vaccination, but the mechanism could not be explained completely by neutralizing antibody or interferon.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183996

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Vaccination against infectious respiratory disease of cattle.

Authors:  K W Jericho
Journal:  Can Vet J       Date:  1983-09       Impact factor: 1.008

2.  Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.

Authors:  Daniel Dory; Anne-Marie Torché; Véronique Béven; Roland Cariolet; André Jestin
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

3.  Modern approaches to understanding stress and disease susceptibility: A review with special emphasis on respiratory disease.

Authors:  Palok Aich; Andrew A Potter; Philip J Griebel
Journal:  Int J Gen Med       Date:  2009-07-30

4.  Cell-mediated cytotoxic responses in lungs following a primary bovine herpes virus type 1 infection.

Authors:  M Campos; P Griebel; H Bielefeldt Ohmann; L A Babiuk
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

5.  Experimental infectious respiratory disease in groups of calves: lobar distribution, variance, and sample-size requirements for vaccine evaluation.

Authors:  K W F Jericho; G C Kozub
Journal:  Can J Vet Res       Date:  2004-04       Impact factor: 1.310

6.  The relationship of serology and nasal microbiology to pulmonary lesions in feedlot cattle.

Authors:  W D Yates; B F Kingscote; J A Bradley; D Mitchell
Journal:  Can J Comp Med       Date:  1983-07

7.  Susceptibility of bovid herpesvirus 1 to antiviral drugs: in vitro versus in vivo efficacy of (E)-5-(2-Bromovinyl)-2'-deoxyuridine.

Authors:  L A Babiuk; S D Acres; V Misra; P H Stockdale; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

8.  Serum haptoglobin as an indicator of the acute phase response in bovine respiratory disease.

Authors:  D L Godson; M Campos; S K Attah-Poku; M J Redmond; D M Cordeiro; M S Sethi; R J Harland; L A Babiuk
Journal:  Vet Immunol Immunopathol       Date:  1996-06-01       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.